series-b
Stage
1
Investors
About
Orgenesis develops and commercializes platforms and solutions for the decentralized manufacturing and processing of personalized cell and gene therapies at or near the point of care.
Explore Orgenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.